Efficacy and safety of MPC-7869 (R-flurbiprofen), a Selective AB42-Lowering Agent, in Alzheimer's disease (AD): Results of a 12-month phase 2 trial and 1-year follow-on study

Autor: Laughlin, M, Black, SE, Wilcock, G, Haworth, J, Hendrix, S, Zavitz, K, Christensen, D, Binger, M, Bass, S, Edward, S

Publikováno v: JOURNAL OF THE AMERICAN GERIATRICS SOCIETY. 54(4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::39ef69bcb2adb1d8a5cda0f02e469d6f
http://ora.ox.ac.uk/objects/uuid:ff7ca052-3949-4d24-90c2-79873f7fa109

No influence of ischemic preconditioning on running economy.

Autor: Kaur G; Vascular Protection Research Laboratory, Box 2203, Intramural 116, Department of Health and Nutritional Sciences, South Dakota State University, Brookings, SD, 57007, USA., Binger M; Vascular Protection Research Laboratory, Box 2203, Intramural 116, Department of Health and Nutritional Sciences, South Dakota State University, Brookings, SD, 57007, USA., Evans C; Vascular Protection Research Laboratory, Box 2203, Intramural 116, Department of Health and Nutritional Sciences, South Dakota State University, Brookings, SD, 57007, USA., Trachte T; Vascular Protection Research Laboratory, Box 2203, Intramural 116, Department of Health and Nutritional Sciences, South Dakota State University, Brookings, SD, 57007, USA., Van Guilder GP; Vascular Protection Research Laboratory, Box 2203, Intramural 116, Department of Health and Nutritional Sciences, South Dakota State University, Brookings, SD, 57007, USA. gary.vanguilder@sdstate.edu.

Publikováno v: European journal of applied physiology [Eur J Appl Physiol] 2017 Feb; Vol. 117 (2), pp. 225-235. Date of Electronic Publication: 2016 Dec 23.

Investigation of the Growth and Chemical Stability of Composite Metal Gates on Ultra-thin Gate Dielectrics.

Autor: Claflin, B., Binger, M., Lucovsky, G., Yang, H.-Y.

Publikováno v: MRS Online Proceedings Library; 1998, Vol. 532 Issue 1, p171-176, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).

Autor: Binger, Michael, Workman, Paul, Binger, M, Workman, P

Publikováno v: Cancer Chemotherapy & Pharmacology; Jan1991, Vol. 29 Issue 1, p37-47, 11p